Immix Biopharma Inc
IMMX
NASDAQ
Biotechnology
$10.97
USD
+0.05 (+0.46%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $781.21M
Volume 1.3M
Price Target
$21.00 – $27.00
USD
The 3 analysts offering 1-year price forecasts have a max estimate of $27.00 and a min estimate of $21.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$24.33
+$5.1 vs prior
Implied Upside
+121.8%
+46.8% vs prior
Analyst Covering
3
-2 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
38%
Many ratings are older - consensus may be less current
Analyst Agreement
Moderate
Targets show moderate spread across analysts
Mean vs Median
$0.6700 Gap
Median $25.00 vs avg $24.33 - a few cautious outliers are pulling the average down
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
3 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0
3 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Robert Burns | HC Wainwright & Co. | Buy | Maintained | 5 days ago | Plus | Plus | Plus |
Gil Blum | Needham | Buy | Initiated | 3 weeks ago | Plus | Plus | Plus |
Tazeen Ahmad | B of A Securities | Buy | Initiated | 1 month ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
GYRE
Gyre Therapeutics Inc
$6.68
▲ +2.1%
ACHV
Achieve Life Sciences Inc
$7.59
▲ +4.7%
MNPR
Monopar Therapeutics Inc
$113.04
▲ +2.4%
AURA
Aura Biosciences Inc
$7.69
▲ +0.5%
BBOT
BridgeBio Oncology Therapeutics Inc
$9.06
▼ -1.8%
CTMX
CytomX Therapeutics Inc
$3.36
▲ +0.3%
STTK
Shattuck Labs Inc
$7.42
▲ +1.4%
RIGL
Rigel Pharmaceuticals Inc
$42.58
▲ +4.4%
FTH
Faeth Therapeutics, Inc
$32.34
▲ +13.3%